Back to HQI overview

HireQuest (HQI): The Franchise toll Road Turns Toward Recovery

Published September 15, 202621 min read·TickerFile Research · HireQuest, Inc. (HQI)
ShareXLinkedIn

The investment case for HireQuest rests on a simple observation about how the company earns its income. Rather than carrying workers on its own payroll the way a conventional staffing agency does, HireQuest collects royalties on the sales of roughly 250 franchised offices, so nearly all of its reported revenue converts straight into earnings before costs can absorb it. In the second quarter of 2026 the company turned almost 56 cents of each revenue dollar into adjusted EBITDA, a conversion rate that conventional peers cannot approach. The thesis in one sentence is therefore that a debt free, insider controlled royalty stream priced at roughly twenty two times trailing adjusted earnings offers a leveraged play on a cyclical staffing recovery whose first green shoots appeared in the most recent quarter.

The most important recent development is the return of reported revenue growth in the second quarter, the first year over year increase since late 2024. The mechanism works through the royalty structure: system wide sales at franchisee offices moved up 6.9 percent pro forma for the MRINetwork divestiture, while franchisor operating costs stayed essentially flat, so the incremental royalty flowed almost entirely to the bottom line. SG&A expense fell by about a third from the prior year quarter as divestiture related overhead came out and scale returned, and adjusted EBITDA jumped roughly 42 percent on a six percent reported revenue gain. That gap between top line and profit growth is the entire economic argument for owning a franchisor into a staffing upcycle.

The central tension is that headline arithmetic and underlying demand point in different directions. Reported system wide sales still declined year over year in the second quarter, cash fell to 1.6 million from 3.9 million at year end as receivables ballooned by nearly ten million, and the growth management cites leans partly on immigration enforcement and tariff driven reshoring, both policy artifacts that a court ruling or a trade negotiation could unwind. The same staffing downturn that crushed the royalty base also removed the earnings that once justified a higher share price, and the recovery now priced in is still, by the actual sales data, an expectation rather than an established trend.

The catalyst or timing trigger is the third quarter print due in early November, which management itself flagged as carrying the momentum. Growth accelerated from low single digits early in the second quarter to double digits by its close, and if that exit rate holds through the seasonally true third quarter, the royalty base prints its first clean year over year quarter in nearly two years and the market re-rates the multiple. Until that confirmation arrives, the price has run ahead of the verified trend, and the stock trades closer to hope than to proof.